Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Prebiotic fiber and exercise may ease inflammation in kidney patients

NCT ID NCT03689569

First seen Apr 28, 2026 · Last updated Jun 23, 2026 · Updated 8 times

Summary

This study looked at whether taking a prebiotic fiber (resistant starch) and doing moderate aerobic exercise for 16 weeks could reduce inflammation and improve blood vessel health, thinking, and mood in people with stage 3-4 chronic kidney disease. 68 patients were randomly assigned to receive the prebiotic or a placebo, with some also exercising. The goal was to see if these lifestyle changes could help manage the disease before dialysis is needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Springfield College

    Springfield, Massachusetts, 01109, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

resistant starch (a type of prebiotic fiber)

What this could lead to

If it works, this could point toward a simple, non-drug way to manage inflammation and slow kidney disease progression.

What could go wrong

This is a small, early-stage study with only 68 participants. Results may not apply to everyone, and the benefits of prebiotics and exercise may be modest or hard to separate from other factors.

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome Inflammation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.